Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Liu X, Ma J, Qiu X, Hong D, et al. Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients. Eur J Dermatol 2021;31:846-847.
PMID: 35107075


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016